can glp 1 cause weight gain Study finds GLP-1 receptor agonists target fat over muscle for loss New research is taking a
Description
PlexusDx explores the clinical evidence, safety considerations, and personalized alternatives for patients seeking advanced metabolic support
The majority of T2D management is in primary care, where clinicians (medical, nursing and pharmacist staff) play an important role in addressing patient needs and achieving treatment goals

Learn about GLP-1 receptor agonists (exenatide, liraglutide, semaglutide, tirzepatide) their mechanism, dosing, cautions, side effects, and interactions

The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.

Ro first integrated directly with Novo Nordisk in April 2025 and has been a key part of the manufacturer's direct-to-patient expansion to date.

SafInside patented saffron extract, titrated at 2% safranal and 3% crocins
